{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Disubstituted pyrazolines and triazolines as factor Xa inhibitors", "item": "https://www.patentleaderboard.com/patent/6191159"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Disubstituted pyrazolines and triazolines as factor Xa inhibitors

Disubstituted pyrazolines and triazolines as factor Xa inhibitors

US Patent 6191159 · Granted Feb 20, 2001

Estimated economic value: $549,377,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Phenylacetamides as inhibitors of rock2022
Five membered-aminoheterocycle and 5,6-or 6,6-membered bicyclic aminoheterocycli2022
Spiroheptane salicylamides and related compounds as inhibitors of ROCK2020
Factor XIa macrocycle inhibitors bearing a non-aromatic P2' group2020
Spiroheptane salicylamides and related compounds as inhibitors of rock2020
Substituted glycine derived FXIA inhibitors2019
Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors2019
Substituted 4,5,6,7-tetrahydropyrazolo[3,4-c]pyridines as factor XIa inhibitors2018
Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors2018
Tetrahydroisoquinolines containing substituted azoles as factor XIa inhibitors2017
Substituted 4,5,6,7-tetrahydropyrazolo[4,3-c]pyridines as factor XIa inhibitors2017
Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors2016